Not applicableStudy completedNCT01771562What this trial is testingNutritional and Metabolic Disorders in HIV Infected Children and AdolescentWho this might be right forHIV-1 ANRS, Emerging Infectious Diseases 330
Testing effectiveness (Phase 2)UnknownNCT06282783What this trial is testingStudying Topiramate for Re-Activating the HIV-1 ReservoirWho this might be right forHIV-1-infectionHivHIV Infections+1 more Erasmus Medical Center 12
Not applicableUnknownNCT05699785What this trial is testingComparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual TherapyWho this might be right forHiv Centre Hospitalier Universitaire de Nice 500
Not applicableLooking for participantsNCT04160455What this trial is testingStudy of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.Who this might be right forAutophagyGalectinsHIV Infections+1 more Centre Hospitalier Régional d'Orléans 180
Not applicableStudy completedNCT01452503What this trial is testingAssessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6Who this might be right forContraception FHI 360 170
Post-approval studies (Phase 4)Study completedNCT01535235What this trial is testingACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot StudyWho this might be right forHIV University of California, San Francisco 31
Early research (Phase 1)Study completedNCT01982396What this trial is testingPharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected ChildrenWho this might be right forHIV Infection PENTA Foundation 19
Post-approval studies (Phase 4)Study completedNCT01736761What this trial is testingA Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.Who this might be right forHIV St Stephens Aids Trust 36
Not applicableStudy completedNCT01836003What this trial is testingAn Intervention to Improve Antenatal Access to CD4 Testing and HAART in BotswanaWho this might be right forHIV InfectionPregnancy Harvard School of Public Health (HSPH) 422
Not applicableActive Not RecruitingNCT01790373What this trial is testingEvaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment AdherenceWho this might be right forHIV Washington University School of Medicine 702
Not applicableStudy completedNCT01776151What this trial is testingArterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)Who this might be right forCardiovascular DiseasesHIV University of Minnesota 337
Not applicableStudy completedNCT01366690What this trial is testingThe PeerCARE Study (Peer Community-based Assistant in REtention)Who this might be right forHIV Johns Hopkins University 250
Testing effectiveness (Phase 2)Study completedNCT00991289What this trial is testingNitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected SubjectsWho this might be right forHIV InfectionHepatitis C Infection National Institute of Allergy and Infectious Diseases (NIAID) 68
Not applicableLooking for participantsNCT06834113What this trial is testingImpact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality HeadsetWho this might be right forHIV I InfectionInjection Pain Centre Hospitalier Régional d'Orléans 120
Post-approval studies (Phase 4)Study completedNCT00442962What this trial is testingHIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIVWho this might be right forHIV Infections Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 54
Not applicableEnded earlyNCT00146094What this trial is testingBone Mineral Density (BMD) in HIV InfectionWho this might be right forOsteopeniaOsteoporosis University Hospital, Strasbourg, France 44
Not applicableStudy completedNCT02827227What this trial is testingValues of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)Who this might be right forHIV-infected Patients Hospices Civils de Lyon 99
Not applicableStudy completedNCT00001131What this trial is testingEffectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT01338883What this trial is testingEfficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic VirusWho this might be right forHIV-1 Infection Tobira Therapeutics, Inc. 143
Testing effectiveness (Phase 2)Ended earlyNCT00196651What this trial is testingHIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary InfectionWho this might be right forHIV Infection French National Agency for Research on AIDS and Viral Hepatitis 60